NSEStatement of deviation(s) or variation(s) under Reg. 32Results4 Nov 2026
Krishna Institute of Medical Sciences Limited
Statement of deviation(s) or variation(s) under Reg. 32
Krishna Institute of Medical Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming NIL deviation or variation in the utilisation of proceeds of funds raised through issue of Warrants to the Promoter & Promoter group of the Company.
NSEStatement of deviation(s) or variation(s) under Reg. 32Results4 Nov 2026
Krishna Institute of Medical Sciences Limited
Statement of deviation(s) or variation(s) under Reg. 32
Krishna Institute of Medical Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming NIL deviation or variation in the utilisation of proceeds of funds raised through Qualified Institutional Placement from the objects stated in Placement Document dated 19th June, 2026.
NSEOutcome of Board MeetingResults4 Nov 2026
Wanbury Limited
Outcome of Board Meeting
Wanbury Limited has submitted its unaudited financial results for the quarter ended September 30, 2026, and the board of directors has approved the results. The results will be uploaded on the company's website.
BSEBoard MeetingResults4 Nov 2026
TCC Concept Ltd
As per the attached.
TCC Concept Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report by its statutory auditors. The results include trade receivables of ₹9.32 crore outstanding since the beginning of the year, with management considering the provision held to be adequate but lacking sufficient evidence to comment on recoverability.
NSEStatement of deviation(s) or variation(s) under Reg. 32Results4 Nov 2026
Shukra Pharmaceuticals Limited
Statement of deviation(s) or variation(s) under Reg. 32
Shukra Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming no deviation or variation in the utilization of proceeds from the object mentioned in the notice of Extra Ordinary general meeting for issuance of convertible warrants on a preferential basis.
BSEBoard MeetingResults4 Nov 2026
Apollo Finvest India Ltd
Approval of Unaudited financial results of the Company for the quarter and half year ended September 30, 2026 and other agenda
Apollo Finvest India Ltd has approved its unaudited financial results for the quarter and half year ended September 30, 2026, and the meeting of the Board of Directors has concluded.
BSEResultResults4 Nov 2026
Trigyn Technologies Ltd
Please find attached herewith the results
Trigyn Technologies Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, and reconstituted its Audit Committee and Nomination and Remuneration Committee.
NSEOutcome of Board MeetingResults4 Nov 2026
Lohia Corp Limited
Outcome of Board Meeting
Lohia Corp Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, and announced the resignation of its Whole-time Director, Mr. Rajendra Kumar Arya, and the reconstitution of its Board Committees.
NSEOutcome of Board MeetingResults4 Nov 2026
Shukra Pharmaceuticals Limited
Outcome of Board Meeting
Shukra Pharmaceuticals Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, showing a net profit of ₹1,601.20 lakhs.
BSEResultResults4 Nov 2026
NRB Bearings Ltd
Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2026
NRB Bearings Ltd has announced unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company has declared an interim dividend of Rs. 2.50 per equity share and fixed November 11, 2026, as the record date. The Board has also reconstituted the Nomination and Remuneration Committee and adopted new policies, including a Sustainability Policy and a Biodiversity Policy.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults4 Nov 2026
Biocon Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Biocon Limited has informed the Exchange about the link for the audio and video recording of the Q2 FY27 Earnings Call conducted on November 04, 2026.
NSEUpdatesResults4 Nov 2026
Sadbhav Engineering Limited
Updates
Sadbhav Engineering Limited has informed the Exchange regarding 'Outcome of Board Meeting held on November 04, 2026 for Unaudited Financial Results for quarter and half year ended on September 30, 2026 and other business matters.' The company has approved and adopted the standalone and consolidated Unaudited Financial Results of the Company for Quarter and half year ended on 30th September, 2026. Additionally, the Board has considered and approved the Resignation of Statutory Auditors of the Company M/s. Manubhai & Shah LLP, Chartered Accountants w.e.f. 04th November, 2026.
BSEBoard MeetingResults4 Nov 2026
Oricon Enterprises Ltd-$
Outcomes of Board Meeting held on November 04,2026 for considered and approve unaudited standalone & Consolidated Financial Results for Quarter /half year ended September 30,2026
Oricon Enterprises Ltd has announced its unaudited standalone and consolidated financial results for the quarter/half-year ended September 30, 2026, which were approved by the Board of Directors at their meeting held on November 04, 2026. The company has also changed its registered office address.
BSEResultResults4 Nov 2026
Apollo Finvest India Ltd
Result- Financial Result for September 30, 2026
Apollo Finvest India Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, which will be available on its website.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults4 Nov 2026
Parag Milk Foods Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Parag Milk Foods Limited has informed the exchange about the availability of the audio recording of its earnings conference call for the quarter and half year ended September 30, 2026, on its website.
BSECompany UpdateResults4 Nov 2026
Biocon Ltd
Audio and Video Recording of Q2 FY27 Earnings Call
Biocon Ltd has announced the audio and video recording of its Q2 FY27 earnings call, available on its website and the link provided.
NSEGeneral UpdatesResults4 Nov 2026
All Time Plastics Limited
General Updates
All Time Plastics Limited has informed the Exchange about General Updates, including unaudited financial results for the quarter and half year ended September 30, 2026, and the transfer of Mr. Rahul Vohra from All Time Plastics Limited to All Time Bamboo Private Limited, a Wholly Owned Subsidiary company. The company has also approved further investment of ₹5,00,00,000/- in All Time Bamboo Private Limited.
BSEResult▲ PositiveResults4 Nov 2026
Aurobindo Pharma Ltd
Submission of Financial results for the Quarter and Half year ended September 30, 2026.
Aurobindo Pharma Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with a standalone profit after tax from continuing operations of Rs. 7,235.8 million. The company has also declared an interim dividend of 700% and approved the re-appointment of a director.
NSEOutcome of Board MeetingResults4 Nov 2026
Galaxy Surfactants Limited
Outcome of Board Meeting
Galaxy Surfactants Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, along with an interim dividend of Rs.18 per equity share, re-appointment of Managing Director, change in Company Secretary, and appointment of Statutory Auditors.
BSECompany UpdateResults4 Nov 2026
All Time Plastics Ltd
Regulation 30 updates
All Time Plastics Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, along with the transfer of Mr. Rahul Vohra from the company to its subsidiary and further investment in the subsidiary.